Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Short-term Investments (2019 - 2025)

Historic Short-term Investments for Sunshine Biopharma (SBFM) over the last 5 years, with Q1 2025 value amounting to $70457.0.

  • Sunshine Biopharma's Short-term Investments changed N/A to $70457.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $70457.0, marking a year-over-year change of. This contributed to the annual value of $7590.0 for FY2021, which is 0.0% changed from last year.
  • According to the latest figures from Q1 2025, Sunshine Biopharma's Short-term Investments is $70457.0.
  • In the past 5 years, Sunshine Biopharma's Short-term Investments registered a high of $70457.0 during Q1 2025, and its lowest value of $7590.0 during Q1 2021.
  • In the last 3 years, Sunshine Biopharma's Short-term Investments had a median value of $7590.0 in 2021 and averaged $15448.4.
  • Data for Sunshine Biopharma's Short-term Investments shows a peak YoY increase of 0.0% (in 2021) and a maximum YoY decrease of 0.0% (in 2021) over the last 5 years.
  • Quarter analysis of 3 years shows Sunshine Biopharma's Short-term Investments stood at $7590.0 in 2021, then changed by 0.0% to $7590.0 in 2022, then skyrocketed by 828.29% to $70457.0 in 2025.
  • Its Short-term Investments stands at $70457.0 for Q1 2025, versus $7590.0 for Q3 2022 and $7590.0 for Q2 2022.